NTN1 and idiopathic pulmonary fibrosis: Finally, UNAGI also illuminates potential IPF pathways that could be targeted for therapeutic interventions like Netrin-1 signaling and Signaling by ROBO receptors, as well as drugs that may reverse these pathways.